PL2066679T3 - Koniugaty disorazoli i ich pochodnych z cząsteczkami wiążącymi się z komórką, nowe pochodne disorazolu, sposoby ich wytwarzania i ich zastosowanie - Google Patents
Koniugaty disorazoli i ich pochodnych z cząsteczkami wiążącymi się z komórką, nowe pochodne disorazolu, sposoby ich wytwarzania i ich zastosowanieInfo
- Publication number
- PL2066679T3 PL2066679T3 PL07803270.3T PL07803270T PL2066679T3 PL 2066679 T3 PL2066679 T3 PL 2066679T3 PL 07803270 T PL07803270 T PL 07803270T PL 2066679 T3 PL2066679 T3 PL 2066679T3
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- disorazoles
- conjugates
- processes
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84235706P | 2006-09-06 | 2006-09-06 | |
| EP06018750A EP1900742A1 (en) | 2006-09-07 | 2006-09-07 | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2066679T3 true PL2066679T3 (pl) | 2016-09-30 |
Family
ID=37670733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07803270.3T PL2066679T3 (pl) | 2006-09-06 | 2007-09-06 | Koniugaty disorazoli i ich pochodnych z cząsteczkami wiążącymi się z komórką, nowe pochodne disorazolu, sposoby ich wytwarzania i ich zastosowanie |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7741277B2 (pl) |
| EP (2) | EP1900742A1 (pl) |
| KR (1) | KR101532966B1 (pl) |
| AR (1) | AR062685A1 (pl) |
| AU (1) | AU2007293650B2 (pl) |
| CA (1) | CA2662308C (pl) |
| DK (1) | DK2066679T3 (pl) |
| ES (1) | ES2572183T3 (pl) |
| HU (1) | HUE028061T2 (pl) |
| MX (2) | MX2009002483A (pl) |
| NZ (1) | NZ575032A (pl) |
| PL (1) | PL2066679T3 (pl) |
| RS (1) | RS54857B1 (pl) |
| SI (1) | SI2066679T1 (pl) |
| TW (1) | TWI346116B (pl) |
| WO (1) | WO2008028934A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1900742A1 (en) * | 2006-09-07 | 2008-03-19 | AEterna Zentaris GmbH | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| EP2341942A1 (en) | 2008-09-19 | 2011-07-13 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
| WO2010033224A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
| CA2752608A1 (en) * | 2009-02-20 | 2010-08-26 | Ipsen Pharma S.A.S. | Cytotoxic conjugates having neuropeptide y receptor binding compound |
| US20120004182A1 (en) * | 2010-07-02 | 2012-01-05 | Carsten Gruendker | Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells |
| CN110133300B (zh) * | 2012-03-18 | 2022-02-25 | 镜株式会社 | 疾病样品分析装置、分析系统及分析方法 |
| KR101974583B1 (ko) | 2012-08-29 | 2019-05-02 | 삼성전자주식회사 | 링커 폴리펩티드 및 이를 이용한 표적 물질 분석 방법 |
| EP3641891A4 (en) * | 2017-06-22 | 2021-01-27 | William Marsh Rice University | SYNTHESIS OF DISORAZOLES AND THEIR ANALOGUES AS POWERFUL ANTI-CANCER AGENTS |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214969B1 (en) | 1988-10-21 | 2001-04-10 | The Administrators Of The Tulane Educational Fund | Luteinizing hormone releasing hormone analogs with cytotoxic moiety |
| US5866679A (en) | 1994-06-28 | 1999-02-02 | Merck & Co., Inc. | Peptides |
| US5843903A (en) | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| CA2265476A1 (en) | 1996-09-12 | 1998-03-19 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| DE19728737C1 (de) | 1997-07-04 | 1999-02-11 | Johannes Christian Groeninghen | Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten |
| AU740597B2 (en) | 1997-07-10 | 2001-11-08 | Merck & Co., Inc. | Conjugates useful in the treatment of prostate cancer |
| AR042617A1 (es) * | 2002-08-24 | 2005-06-29 | Zentaris Gmbh | Disorazoles y sus derivados, utiles para el tratamiento de enfermedades tumorales benignas y malignas, y el uso de dichos compuestos para la preparacion de medicamentos. |
| US7364877B2 (en) | 2002-12-06 | 2008-04-29 | Kosan Biosciences, Inc. | Polynucleotides encoding disorazole polyketide synthase polypeptides |
| WO2005112919A2 (en) * | 2004-05-19 | 2005-12-01 | Medarex, Inc. | Self-immolative linkers and drug conjugates |
| US20060199252A1 (en) * | 2005-01-13 | 2006-09-07 | Herbert Irschik | Genes encoding the synthetic pathway for the production of disorazole |
| EP1838848A1 (en) | 2005-01-13 | 2007-10-03 | Helmholtz-Zentrum für Infektionsforschung GmbH | Genes encoding the synthetic pathway for the production of disorazole |
| WO2006135371A1 (en) * | 2005-06-09 | 2006-12-21 | Kosan Biosciences Incorporated | Conjugates with reduced adverse systemic effects |
| EP1743897A1 (en) * | 2005-07-15 | 2007-01-17 | Gesellschaft für Biotechnologische Forschung mbH | Biologically active compounds obtainable from Sorangium cellulosum |
| EP1900742A1 (en) * | 2006-09-07 | 2008-03-19 | AEterna Zentaris GmbH | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
-
2006
- 2006-09-07 EP EP06018750A patent/EP1900742A1/en not_active Withdrawn
-
2007
- 2007-09-06 HU HUE07803270A patent/HUE028061T2/en unknown
- 2007-09-06 SI SI200731775A patent/SI2066679T1/sl unknown
- 2007-09-06 WO PCT/EP2007/059310 patent/WO2008028934A1/en active Application Filing
- 2007-09-06 AU AU2007293650A patent/AU2007293650B2/en not_active Ceased
- 2007-09-06 MX MX2009002483A patent/MX2009002483A/es active IP Right Grant
- 2007-09-06 MX MX2011010178A patent/MX337358B/es unknown
- 2007-09-06 KR KR1020097007093A patent/KR101532966B1/ko not_active IP Right Cessation
- 2007-09-06 NZ NZ575032A patent/NZ575032A/en not_active IP Right Cessation
- 2007-09-06 ES ES07803270T patent/ES2572183T3/es active Active
- 2007-09-06 DK DK07803270.3T patent/DK2066679T3/en active
- 2007-09-06 EP EP07803270.3A patent/EP2066679B1/en active Active
- 2007-09-06 RS RS20160412A patent/RS54857B1/sr unknown
- 2007-09-06 CA CA2662308A patent/CA2662308C/en not_active Expired - Fee Related
- 2007-09-06 PL PL07803270.3T patent/PL2066679T3/pl unknown
- 2007-09-06 AR ARP070103942A patent/AR062685A1/es not_active Application Discontinuation
- 2007-09-06 TW TW096133272A patent/TWI346116B/zh not_active IP Right Cessation
- 2007-09-06 US US11/850,747 patent/US7741277B2/en not_active Expired - Fee Related
-
2010
- 2010-03-19 US US12/728,050 patent/US8470776B2/en not_active Expired - Fee Related
- 2010-03-19 US US12/728,075 patent/US20100323963A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009002483A (es) | 2009-03-23 |
| KR20090064436A (ko) | 2009-06-18 |
| RS54857B1 (sr) | 2016-10-31 |
| NZ575032A (en) | 2011-02-25 |
| DK2066679T3 (en) | 2016-06-27 |
| US7741277B2 (en) | 2010-06-22 |
| US20080090758A1 (en) | 2008-04-17 |
| EP1900742A1 (en) | 2008-03-19 |
| RU2009112546A (ru) | 2010-10-20 |
| SI2066679T1 (sl) | 2016-06-30 |
| US8470776B2 (en) | 2013-06-25 |
| AR062685A1 (es) | 2008-11-26 |
| MX337358B (es) | 2016-02-29 |
| HUE028061T2 (en) | 2016-11-28 |
| WO2008028934A1 (en) | 2008-03-13 |
| US20100317580A1 (en) | 2010-12-16 |
| EP2066679A1 (en) | 2009-06-10 |
| AU2007293650B2 (en) | 2012-06-14 |
| EP2066679B1 (en) | 2016-03-09 |
| KR101532966B1 (ko) | 2015-07-02 |
| AU2007293650A1 (en) | 2008-03-13 |
| WO2008028934A8 (en) | 2008-05-02 |
| CA2662308C (en) | 2014-10-28 |
| TW200823228A (en) | 2008-06-01 |
| ES2572183T3 (es) | 2016-05-30 |
| US20100323963A1 (en) | 2010-12-23 |
| TWI346116B (en) | 2011-08-01 |
| CA2662308A1 (en) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2395012B8 (en) | Modified siRNA molecules and uses thereof | |
| EP2067782A4 (en) | HETERACENE DERIVATIVE, TETRAHALOTHERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | |
| AU2007313300A8 (en) | Molecules with reduced half-lives, compositions and uses thereof | |
| IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
| EP2268813A4 (en) | RNA MOLECULES AND THEIR USE | |
| IL195876A0 (en) | Pyrazine derivatives with extended conjugation and uses thereof | |
| HK1140202A1 (en) | Novel pyridopyrazine derivatives, process of manufacturing and uses thereof | |
| IL218716A0 (en) | Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof | |
| IL189187A (en) | Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses | |
| EP1990337A4 (en) | CHINAZOLINE DERIVATIVES, METHOD OF MANUFACTURE AND USES THEREOF | |
| TWI346116B (en) | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof | |
| ZA201001206B (en) | Saccharide-containing protein conjugates and uses thereof | |
| GB0808916D0 (en) | Production of conjugates | |
| IL206060A0 (en) | Conjugates of anti-rg-1 antibodies, compositions comprising the same and uses thereof | |
| EP2040242A4 (en) | FOLDABLE LABEL, ARTICLE WITH FOLDABLE LABEL, AND METHOD OF MANUFACTURING THE ARTICLE | |
| IL196866A (en) | Erythropoietin compounds, pharmaceuticals containing them and their uses | |
| ZA200900302B (en) | Composition, article, its manufacture and use | |
| IL195430A0 (en) | Arylsulfonamidyl tetralin derivatives and uses thereof | |
| HRP20160631T1 (hr) | Konjugati disorazola i njihovi derivati sa staničnovezajućim molekulama, novi derivati disorazola, postupci njihove pripreme i njihove uporabe | |
| ZA200901177B (en) | Conjugates of disorazoles and their derivatives with cellbinding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof | |
| GB2469959B (en) | Dioctatin derivatives and production process thereof | |
| AU2007905753A0 (en) | Novel Immunogenic Molecules and Uses Thereof | |
| GB0616531D0 (en) | The medicinal uses of molecules and their derivatives | |
| ZA200808225B (en) | Substituted prolinamides, production thereof and their use as drugs | |
| GB0715513D0 (en) | The medicinal uses of molecules and their derivatives |